By Kelly Cloonan
Acrivon Therapeutics has appointed Dr. Mansoor Raza Mirza as chief medical officer, effective Wednesday.
Dr. Mirza joins the Watertown, Mass. clinical stage precision medicine company from Denmark's Copenhagen University National Medical Center, where he served as chief oncologist, Acrivon said Monday.
Mirza succeeds Dr. Jean-Marie Cuillerot, who entered the role in January of last year.
Mirza brings decades of clinical research and patient care experience, and specializes in gynecologic malignancies, or cancers affecting female reproductive organs, the company said.
Write to Kelly Cloonan at kelly.cloonan@wsj.com
(END) Dow Jones Newswires
April 07, 2025 18:14 ET (22:14 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。